SCHEMBL19485437

SCHEMBL19485437

Cc1cccc(OCCCC(=O)N(C)C)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.60
KMT2A Q03164 3/20 0.60
MAPT P10636 2/20 0.60
MEN1 O00255 2/20 0.60
NPC1 O15118 1/20 0.60
ALDH1A1 P00352 1/20 0.60
MAPK1 P28482 1/20 0.60
RAB9A P51151 1/20 0.60
HPGD P15428 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
LMNA P02545 2/20 0.55
GAA P10253 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
POLB P06746 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568926 0.85 KMT2A (0.55) SMN1; SMN2KMT2AALDH1A1CYP2D6
SCHEMBL19485436 0.84 SMN1; SMN2 (0.53) SMN1; SMN2KMT2AMAPTMEN1NPC1
SCHEMBL2205020 0.84 PDK2 (0.49) SMN1; SMN2NPC1ALDH1A1MAPK1LMNA
SCHEMBL29818912 0.84 PDK2 (0.49) SMN1; SMN2NPC1ALDH1A1MAPK1LMNA
SCHEMBL6850974 0.83 SMN1; SMN2 (0.65) SMN1; SMN2KMT2AMAPTMEN1NPC1
SCHEMBL12217570 0.83 SMN1; SMN2 (0.59) SMN1; SMN2KMT2AMAPTMEN1ALDH1A1
SCHEMBL13523837 0.83 SMN1; SMN2 (0.65) SMN1; SMN2KMT2AMAPTMEN1NPC1
SCHEMBL826321 0.83 SMN1; SMN2 (0.65) SMN1; SMN2KMT2AMAPTMEN1NPC1
SCHEMBL10054169 0.82 L3MBTL1 (0.62) SMN1; SMN2KMT2AMAPTMEN1NPC1
SCHEMBL11550936 0.81 SMN1; SMN2 (0.63) SMN1; SMN2KMT2AMAPTMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795687-B2 Modularly assembled small molecules for the treatment of myotonic dystrophy type 1 THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-24 US disclosed
US-9795687-B2 Modularly assembled small molecules for the treatment of myotonic dystrophy type 1 THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-24 US disclosed